These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2109270)

  • 1. Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemia.
    Kooy A; de Greef WJ; Vreeburg JT; Hackeng WH; Ooms MP; Lamberts SW; Weber RF
    Neuroendocrinology; 1990 Mar; 51(3):261-6. PubMed ID: 2109270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo release of dopamine, luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in male rats bearing a prolactin-secreting tumor.
    Voogt JL; de Greef WJ; Visser TJ; de Koning J; Vreeburg JT; Weber RF
    Neuroendocrinology; 1987 Aug; 46(2):110-6. PubMed ID: 3114662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LH-RH and dopamine levels in hypophysial stalk plasma and their relationship to plasma gonadotrophins and prolactin levels in male rats bearing a prolactin- and adrenocorticotrophin-secreting pituitary tumor.
    Weber RF; de Greef WJ; de Koning J; Vreeburg JT
    Neuroendocrinology; 1983; 36(3):205-10. PubMed ID: 6300718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of corticotropin-releasing factor.
    de Greef WJ; Ooms MP; Vreeburg JT; Weber RF
    Neuroendocrinology; 1995 Jan; 61(1):19-26. PubMed ID: 7731494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of experimentally-induced chronic hyperprolactinemia on testosterone and gonadotropin levels in male rats and mice.
    Bartke A; Smith MS; Michael SD; Peron FG; Dalterio S
    Endocrinology; 1977 Jan; 100(1):182-6. PubMed ID: 830537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prolactin on the secretion of hypothalamic GnRH and pituitary gonadotropins.
    Koike K; Miyake A; Aono T; Sakumoto T; Ohmichi M; Yamaguchi M; Tanizawa O
    Horm Res; 1991; 35 Suppl 1():5-12. PubMed ID: 1752606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA; Esquifino AI
    Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a prolactin- and adrenocorticotropin-secreting tumor on gonadotropin levels and accessory sex organ weights in adult male rats: a possible role of the adrenals.
    Weber RF; Ooms MP; Vreeburg JT
    Endocrinology; 1982 Aug; 111(2):412-7. PubMed ID: 6284478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal relationships between the circadian rhythmicity in plasma levels of pituitary hormones and in hypothalamic concentrations of releasing factors.
    Szafarczyk A; Hery M; Laplante E; Ixart G; Assenmacher I; Kordon C
    Neuroendocrinology; 1980 Jun; 30(6):369-76. PubMed ID: 6247669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of passive immunization against corticotropin-releasing factor (CRF) on the postadrenalectomy changes of CRF binding sites in the rat anterior pituitary gland.
    Grino M; Guillaume V; Castanas E; Boudouresque F; Conte-Devolx B; Oliver C
    Neuroendocrinology; 1987 Jun; 45(6):492-7. PubMed ID: 3039393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin secretion in rats bearing a prolactin-secreting pituitary tumor: effects of naloxone administration.
    Lamberts SW; Zuiderwijk JM; Bons EG; Uitterlinden P; de Jong FH
    Fertil Steril; 1981 May; 35(5):557-62. PubMed ID: 6785115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by corticotropin-releasing factor.
    Grino M; Burgunder JM; Eskay RL; Eiden LE
    Endocrinology; 1989 Jun; 124(6):2686-92. PubMed ID: 2524376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hyperprolactinemia produced by transplantable pituitary MtTW15 tumor cells in male rats on hypothalamic luteinizing hormone-releasing hormone release in vitro: effects of naloxone and K+.
    Kalra PS; Kalra SP
    Endocrinology; 1987 Jul; 121(1):310-5. PubMed ID: 3297642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new prolactin-producing tumour 7315b on gonadotrophin secretion in adult male and female rats.
    Kooy A; Weber RF; Ooms MP; Vreeburg JT
    J Endocrinol; 1989 Feb; 120(2):261-8. PubMed ID: 2494282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.
    Fox SR; Hoefer MT; Bartke A; Smith MS
    Neuroendocrinology; 1987 Oct; 46(4):350-9. PubMed ID: 2823160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of prolactin and pituitary-adrenal axis components as intervening variables in the adrenalectomy-induced inhibition of gonadotropin response to castration.
    Ringstrom SJ; Schwartz NB
    Endocrinology; 1984 Mar; 114(3):880-7. PubMed ID: 6321145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous human growth hormone (GH) modulates the effect of gonadotropin-releasing hormone on pituitary function and the gonadotropin response to the negative feedback effect of testosterone in adult male transgenic mice bearing human GH gene.
    Chandrashekar V; Bartke A; Wagner TE
    Endocrinology; 1988 Dec; 123(6):2717-22. PubMed ID: 3143542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.